Mandatory notification of trade

29. Aug 2023 | 1 min read

Moss, 29 August 2023

Gentian Diagnostics ASA has today been notified that primary insider Njaal Kind (CFO) on 29 August 2023 purchased 5,000 shares at an average price of 43,40 per share. After the transaction Mr. Kind holds 26,125 shares and 140,670 options in Gentian Diagnostics ASA.

This information is subject to the disclosure requirements in the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

To see the announcement follow this link: https://newsweb.oslobors.no/message/598195

You may also read


Mar 20, 2026 - Ole Sørlie

Gentian Diagnostics: Annual report 2025

Moss, 20 March 2026 Gentian Diagnostics has today published its annual report for 2025. The annual report and..

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Employee Share Purchase Program and share capital increase

Moss, 12 March 2026 Gentian Diagnostics ASA (the "Company") has completed the offer of new shares to..